As of 2024-12-15, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (3.44) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.89 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -282.2%.
The range of the Relative Valuation is (3.05) - (4.07) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.9x - 10.3x | 8.6x |
| Forward P/E multiples | 4.7x - 9.2x | 7.0x |
| Fair Price | (3.05) - (4.07) | (3.44) |
| Upside | -261.2% - -315.6% | -282.2% |
| Date | P/E |
| 2024-12-13 | -4.27 |
| 2024-12-12 | -4.36 |
| 2024-12-11 | -4.58 |
| 2024-12-10 | -4.61 |
| 2024-12-09 | -4.72 |
| 2024-12-06 | -4.70 |
| 2024-12-05 | -4.63 |
| 2024-12-04 | -4.65 |
| 2024-12-03 | -4.88 |
| 2024-12-02 | -4.95 |
| 2024-11-29 | -5.10 |
| 2024-11-28 | -5.22 |
| 2024-11-27 | -4.97 |
| 2024-11-26 | -4.81 |
| 2024-11-25 | -4.92 |
| 2024-11-22 | -5.10 |
| 2024-11-21 | -5.01 |
| 2024-11-20 | -4.92 |
| 2024-11-19 | -5.17 |
| 2024-11-18 | -5.69 |
| 2024-11-15 | -5.74 |
| 2024-11-14 | -5.92 |
| 2024-11-13 | -6.01 |
| 2024-11-12 | -6.03 |
| 2024-11-11 | -6.16 |
| 2024-11-08 | -6.28 |
| 2024-11-07 | -6.55 |
| 2024-11-06 | -6.07 |
| 2024-11-05 | -6.14 |
| 2024-11-04 | -6.01 |
| 2024-11-01 | -5.89 |
| 2024-10-31 | -5.65 |
| 2024-10-30 | -5.71 |
| 2024-10-29 | -5.76 |
| 2024-10-28 | -5.80 |
| 2024-10-25 | -6.07 |
| 2024-10-24 | -5.87 |
| 2024-10-23 | -5.83 |
| 2024-10-22 | -5.83 |
| 2024-10-21 | -5.96 |
| 2024-10-18 | -5.98 |
| 2024-10-17 | -6.07 |
| 2024-10-16 | -5.92 |
| 2024-10-15 | -5.89 |
| 2024-10-11 | -5.89 |
| 2024-10-10 | -5.56 |
| 2024-10-09 | -5.71 |
| 2024-10-08 | -6.07 |
| 2024-10-07 | -5.83 |
| 2024-10-04 | -6.01 |